Search Results
722 results
Your search is now limited to «Diabetes Treatments» expert search.
Technology Org 01/22/2019 03:40
Scientists working to develop more effective treatments for diabetes are turning to stem cells.
More from Technology Org:
American Diabetes Journals 01/21/2019 14:50
OBJECTIVE. Successful self-management of type 1 diabetes requires cognitive skills such as executive functioning (EF). In the transition to adolescence, youth take over responsibility for diabetes management. We set out to test: 1 ) the association between EF and glycemic control over time and 2 ) whether this association was moderated by: a ) youth, shared, or parent responsibility for diabetes management and b ) youth’s age. RESEARCH DESIGN AND METHODS. Within the Diabetes IN DevelOpment study (DINO), parents of youth with type 1 diabetes (8–15 years at baseline; N = 174) completed a yearly assessment over 4 years. Glycemic control (HbA 1c ) was derived from hospital charts. Youth’s EF was measured using the Behavior Rating Inventory of Exe.
More from American Diabetes Journals:
WN.com 01/21/2019 13:24
Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type ... ViaCyte, Inc. ......
More from WN.com:
ClinicalTrials.gov 01/21/2019 12:00
The proprietary electronic medical database in the MMC will help the dynamic big-data analysis in diabetes epidemiology, prevention, diagnosis, and treatment.
More from ClinicalTrials.gov:
PR Newswire 01/21/2019 09:00
ViaCyte is also developing immune-evasive stem cell lines in collaboration with CRISPR Therapeutics, from its proprietary CyT49 cell line, which have the potential to further broaden the availability of cell therapy for diabetes and other indications.
More from PR Newswire:
FeedNavigator 01/20/2019 09:12
Abstract Background and aims Real-world data on treatment patterns in Japanese hyperlipidemia patients with diabetes mellitus (DM) or prior atherosclerotic cardiovascular diseases (ASCVD) are lacking.
More from FeedNavigator:
MedicineNet 01/19/2019 03:20
She agreed there's a need for additional diabetes medications that work through actions that are different from available drugs.
More from MedicineNet:
Diabetes In Control News 01/18/2019 19:10
Leaders in the community, like Ralph Defronzo, suggested that drugs like sulfonylureas had little place in the treatment of diabetes and should be removed from clinical use.
More from Diabetes In Control News:
Laboratory Equipment 01/18/2019 12:30
The drug, dubbed TTP399, was initially evaluated by the researchers in rats, mice and minipigs with success, and hints that TTP399 may someday pave the way to better treatment options for the condition.
More from Laboratory Equipment:
Healio News 01/18/2019 11:10
Endocrine Today has compiled a list of recent news reports about diabetes drugs, including FDA actions and new agents in development.
More from Healio News:
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review and responsiveness by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK.
Benzinga 01/18/2019 07:49
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak. (Biotech stocks hitting 52-week highs on Jan. 17). Avenue Therapeutics Inc (NASDAQ: ATXI ). BioSpecifics Technologies Corp. (NASDAQ: BSTC ). Regeneron Pharmaceuticals Inc (NASDAQ: REGN ). Down In The Dumps. (Biotech stocks hitting 52-week lows on Jan. 17). Amneal Pharmaceuticals Inc (NYSE: AMRX ). Avrobio Inc (NASDAQ: AVRO ). Neuronetics Inc (NASDAQ: STIM ). Sesen Bio Inc (NASDAQ: SESN ). Stock In Focus. FDA Panel Divided On Lexicon-Sanofi's Diabetes Drug. Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX ) said the FDA's Endocrinology and Metabolic Advisory Committee voted 8 to 8 on whether the benefit-risk profile supports the approvability of Sotagliflozin,

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications